Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announ

Signup for news and special announcements!
You have successfully joined our subscriber list.
Seattle's life science market entered the second half of 2026 with the...
ByThe RegistrySeptember 14, 2026Genentech will invest approximately $750 million to double its Hillsboro, Oregon manufacturing...
ByThe RegistryAugust 21, 2026A biomanufacturing facility that Pfizer abandoned two years into a $500 million...
ByThe RegistryAugust 13, 2026Alexandria Real Estate Equities singled out Seattle as one of three markets...
ByThe RegistryAugust 5, 2026